BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Direct-acting antiviral
1
Analysis of hepatitis C virus positive organs in liver transplantation.
9/23/2022 12:48:56 AM | Browse: 232 | Download: 423
2
Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
8/10/2022 8:23:14 AM | Browse: 254 | Download: 714
3
Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis
6/23/2022 2:39:01 PM | Browse: 240 | Download: 745
4
Distribution and changes in hepatitis C virus genotype in China from 2010 to 2020
5/13/2022 8:46:13 AM | Browse: 213 | Download: 395
5
Hepatitis C virus failure to treatment: Clinical utility of testing resistance associated substitutions
9/22/2021 8:09:41 AM | Browse: 389 | Download: 730
6
Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports
12/18/2020 5:58:43 AM | Browse: 529 | Download: 875
7
Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma
9/21/2020 4:02:08 PM | Browse: 489 | Download: 1033
8
Management of hepatitis C in children and adolescents during COVID-19 pandemic
8/25/2020 9:16:00 AM | Browse: 611 | Download: 1082
9
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
11/27/2018 1:56:41 PM | Browse: 881 | Download: 1490
10
Hepatitis C virus infection in children in the era of direct-acting antiviral
6/26/2018 12:26:34 AM | Browse: 1158 | Download: 1206
11
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
3/26/2018 8:48:04 AM | Browse: 1133 | Download: 2010
12
Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses
7/4/2016 2:42:00 PM | Browse: 1016 | Download: 1075
13
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
3/23/2016 4:26:00 PM | Browse: 1271 | Download: 1871
14
Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C
11/18/2015 11:12:00 AM | Browse: 978 | Download: 1548
15
Immune and non-immune responses to hepatitis C virus infection
10/14/2015 12:06:00 PM | Browse: 996 | Download: 1357
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345